DERMATOLOGY UPDATE 2004 SCHEDULE OF EVENTS Thursday, October 14, 2004 Stanley Park Ballroom Topic 9:30 11:00 Case Studies in Onychomycosis Non typical onychomycosis cases will be presented. Interaction with the audience on treatment approaches will be facilitated through touch pads. 2:00 3:30 Shaping the Management of Psoriasis Achieving Long-Term Control 2:00 Introduction: Long-term Control An Unmet Need in Psoriasis Dr. Vincent Ho 2:10 Efalizumab An Innovative Biological that Combines Safety and Efficacy Kim Papp 2:35 Practical Experience Using Efalizumab Alan Menter 2:55 Integrating Biologic Agents into the Management of Moderate to Severe Psoriasis A Canadian Expert Panel Consensus Richard Langley 3:15 Conclusions; Q&A Session Vincent Ho
Thursday, October 14, 2004 Stanley Park Ballroom Topic 4:00 5:00 Novel Findings in Atopic Dermatitis: How To Maximize Treatments Atopic dermatitis (AD), a chronic inflammatory, severely itchy skin disease, with an increasing global prevalence affecting at least 10-20 % of children but which may persist into adulthood, is believed to be the first step in the "atopic march" resulting in asthma and allergic rhinitis. The phenotype of the disease is viewed as the result of the interaction between environmental factors, defective skin barrier function and susceptibility genes resulting in immunological anddistal neurological abnormalities. The enormous progress in our understanding of the complex pathophysiology of AD, as well as our better knowledge of the structure of the barrier function of the skin and of the role of patient therapeutic education, have ultimately allowed the development of novel therapeutic strategies. 4:00 Opening Dr. Danielle Marcoux 4:05 Immunological Aspects of Atopic Dermatitis: What do we know? Dr. Thomas Luger 4:35 Emollients and Barrier Function in Atopic Dermatitis Dr. Andre Rougier 4:55 Patients Therapeutic Education: the Role and Benefits of School of Atopy Dr. Danielle Marcoux 5:20 Question and Answer Panel
Friday, October 15, 2004 Bayshore Ballroom DEF Topic 9:30 11:00 Clinical Advances in the Use of Imiquimod Aldara for AK: Clinical Approaches Dr. Stuart Salasche Immune Response Modifiers - An Innovative Approach to NMSC Prof. Eggert Stockfleth 11:30 1:30 Advancing the Treatment of Psoriasis and Psoriatic Arthritis with Biologic Therapies: Practical Application of Using TNF Antagonists (Lunch provided) By attending this symposium, participants will be able to: Understand the immunologic effect of targeting tumor necrosis factor (TNF) alpha in psoriatic disease Interpret recent clinical trial data for TNF antagonists in the treatment of psoriatic arthritis and psoriasis Distinguish between TNF antagonists based on safety and mechanism of action Rationalize the need to incorporate biologic therapy for psoriatic disease into dermatology practice Describe strategies for optimizing response to TNF antagonists in clinical practice 11:30 Introduction, Learning Objectives Yves P. Poulin, MD, FRCPC 11:40 Biologic Treatment of Psoriatic Arthritis & Psoriasis Kim A. Papp, MD, PhD, FRCPC 12:05 Interpreting the Safety Experience with TNF Antagonists Richard G.B. Langley, MD, FRCPC 12:30 Practical Approaches and Considerations for Using TNF Antagonists in Clinical Practice: US Experience Bruce Strober, MD, PhD 13:10 Close, Q&A Yves Poulin, MD, FRCPC 13:30 Adjourn 2:00 3:30 Redefining Efficacy in Psoriasis
Saturday, October 16, 2004 Bayshore Ballroom DEF Topic Speaker SESSION 1 7:00 8:00 Breakfast 8:00 8:05 Opening Remarks Dr. Harvey Lui Chair: 8:05 8:20 Review of Drugs for the Treatment of Dr. Harvey Lui of Skin Disease Dr. Stuart Maddin 8:20 8:35 Treating Pemphigus Vulgaris with IVIG: Assessing the Strength of Evidence 8:35 8:50 Valycyclovir in the Treatment and Prevention of Herpes Infections 8:50 9:05 Immune Response Modifiers - An Innovative Approach to NMSC Dr. Neil Shear Dr. Stephen Tyring Prof. Eggert Stockfleth 9:05 9:20 Eczema/Corticosteroids Dr. John Berth-Jones 9:20 9:35 Anti-psoriatics / biologics Dr. Alan Menter 9:35 9:55 Panel and Questions 9:55 10:15 Coffee Break and Poster Exhibits SESSION 2 10:15 10:30 Current Management of Atopic Dermatitis Dr. Thomas Luger Chair: 10:30 10:45 Role of Staphylcococcus Aureus Dr. Jan Dutz in Atopic Dermatitis Dr. Donald Leung 10:45 11:00 Psoriasis / Retinoids Dr. Kim Papp 11:00 11:15 TNF Antagonists in the Treatment of Psoriasis and Psoriatic Arthritis: Case Studies Dr. Bruce Strober 11:15 11:30 A Canadian Expert Panel Consensus Integrating Biologic Agents in the Management of Moderate to Severe Psoriasis Dr. Richard Langley 11:30 11:45 Pimecrolimus for Atopic Dermatitis and Where Do We Go From Here? Prof. Klaus Wolff 11:45 12:05 Panel and Questions
Saturday, October 16, 2004 Bayshore Ballroom DEF RAPID FIRE LUNCH Speaker 12:05 2:00 (Bayshore Ballroom ABC) 1. CellCept : A New and Emerging Therapy Dr. Regine Mydlarski Chair: 2. The Effect of Periocular Hemangiomas on Visual Development in Children 3. Treating Mycosis Fungoides: What, How, Why? Dr. Bryce Cowan Dr. Marni Wiseman 4. A Brief Review of Eczema Management Dr. Jim Bergman SESSION 3 2:00 2:15 Genetic Applications in Dermatology Chair: 2:15 2:30 Development of Immune Response Mr. Greg Hines Dr. Jerry Shapiro Modifiers Dr. Richard Miller 2:30 2:55 Photoaging: Update and Treatment 2:55 3:10 Panel and Questions Dr. Sheldon Pinnell 3:10 3:30 Coffee Break and Poster Exhibits SESSION 4 3:30 3:45 Acne Quality of Life Dr. Andrew Finlay 3:45 4:00 PDT and the Sebaceous Gland: Chair: Preclinical Results Dr. David Hunt Dr. Neil Shear 4:00 4:15 Topical Retinoids and their Effect On Inflammatory Mediators in Acne Dr. Sewon Kang 4:15 4:30 An Update on the Management of Onychomycosis Dr. Aditya Gupta 4:30 4:20 Panel and Questions 4:20 4:50 Acute Skin Failure Canadian Consensus Consult Guidelines Dr. Ron Vender Treatment of Acute Skin Failure Dr. Ian Landells and Dr. Kevin Smith Who's Who in Canadian Dermatology Dr. Chuck Lynde The Father of All Azoles Dr. Geert Cauwenbergh Session Summary Dr. Richard Thomas 4:50 5:00 Closing Comments Dr. Stuart Maddin
GALA DINNER 7:30 8:00 Reception (Bayshore Ballroom Foyer) 8:00 11:00 Dinner (Bayshore Ballroom ABC) Please join us in celebrating Dermatology Update s 20 th Anniversary. Attire is business formal or black tie. Pre registration is required (tickets will be on sale until Thursday, October 14 th as all seats will be pre-assigned).